CONSOLE LABS SA ZY-10 (9ZK) - Total Liabilities
Based on the latest financial reports, CONSOLE LABS SA ZY-10 (9ZK) has total liabilities worth €1.04 Million EUR (≈ $1.21 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does CONSOLE LABS SA ZY-10 generate cash to assess how effectively this company generates cash.
CONSOLE LABS SA ZY-10 - Total Liabilities Trend (2021–2024)
This chart illustrates how CONSOLE LABS SA ZY-10's total liabilities have evolved over time, based on quarterly financial data. See CONSOLE LABS SA ZY-10 shareholders equity for net asset value and shareholders' equity analysis.
CONSOLE LABS SA ZY-10 Competitors by Total Liabilities
The table below lists competitors of CONSOLE LABS SA ZY-10 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Avinger Inc
NASDAQ:AVGR
|
USA | $9.73 Million |
|
Ausmon Resources Ltd
AU:AOA
|
Australia | AU$1.20 Million |
|
TrustBIX Inc
V:TBIX
|
Canada | CA$3.35 Million |
|
Yida China Holdings Ltd
STU:YC2
|
Germany | €27.26 Billion |
|
Apogee Minerals Ltd
V:APMI
|
Canada | CA$156.54K |
|
Akanda Corp
NASDAQ:AKAN
|
USA | $2.91 Million |
|
BBS-Bioactive Bone Substitutes Oyj
HE:BONEH
|
Finland | €5.58 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down CONSOLE LABS SA ZY-10's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see CONSOLE LABS SA ZY-10 market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.20 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.68 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how CONSOLE LABS SA ZY-10's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for CONSOLE LABS SA ZY-10 (2021–2024)
The table below shows the annual total liabilities of CONSOLE LABS SA ZY-10 from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €721.16K ≈ $843.11K |
+41.05% |
| 2023-12-31 | €511.26K ≈ $597.72K |
+80.95% |
| 2022-12-31 | €282.54K ≈ $330.32K |
-13.53% |
| 2021-12-31 | €326.76K ≈ $382.02K |
-- |
About CONSOLE LABS SA ZY-10
Console Labs S.A. engages in developing and porting games to other platforms. It also creates its productions for consoles and personal computers. The company was incorporated in 2018 and is based in Gdansk, Poland. Console Labs S.A. is a subsidiary of PlayWay S.A.